158 related articles for article (PubMed ID: 7734204)
1. Li-Fraumeni syndrome.
Birch JM
Eur J Cancer; 1994; 30A(13):1935-41. PubMed ID: 7734204
[No Abstract] [Full Text] [Related]
2. Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
Evans DG; Birch JM; Thorneycroft M; McGown G; Lalloo F; Varley JM
J Med Genet; 2002 Dec; 39(12):941-4. PubMed ID: 12471212
[No Abstract] [Full Text] [Related]
3. [Li-Fraumeni syndrome].
Tokunaga A; Onda M; Matsukura N; Kato S
Nihon Rinsho; 1995 Nov; 53(11):2797-802. PubMed ID: 8538047
[TBL] [Abstract][Full Text] [Related]
4. Novel p53 germline mutation in a patient with Li-Fraumeni syndrome.
Wong SS; Lozano G; Gaff CL; Gardner RJ; Strong LC; Aittomäki K; Lindeman GJ
Intern Med J; 2003 Dec; 33(12):621. PubMed ID: 14656244
[No Abstract] [Full Text] [Related]
5. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
6. Li-Fraumeni syndrome in pediatric patients with soft tissue sarcoma or osteosarcoma.
Carnevale A; Lieberman E; Cárdenas R
Arch Med Res; 1997; 28(3):383-6. PubMed ID: 9291635
[TBL] [Abstract][Full Text] [Related]
7. Li-Fraumeni syndrome.
Ponz de Leon M
Recent Results Cancer Res; 1994; 136():275-86. PubMed ID: 7863100
[No Abstract] [Full Text] [Related]
8. Familial gastric cancer and Li-Fraumeni syndrome.
Corso G; Pedrazzani C; Marrelli D; Pinto E; Roviello F
Eur J Cancer Care (Engl); 2010 May; 19(3):377-81. PubMed ID: 19674071
[TBL] [Abstract][Full Text] [Related]
9. BRCA2: a cause of Li-Fraumeni-like syndrome.
Evans DG; Wu CL; Birch JM
J Med Genet; 2008 Jan; 45(1):62-3. PubMed ID: 18178637
[No Abstract] [Full Text] [Related]
10. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
Menko FH; Nooy MA; Vasen HF
Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
[No Abstract] [Full Text] [Related]
11. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
Sedlacek Z; Kodet R; Kriz V; Seemanova E; Vodvarka P; Wilgenbus P; Mares J; Poustka A; Goetz P
Br J Cancer; 1998 Apr; 77(7):1034-9. PubMed ID: 9569035
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
Bell DW; Varley JM; Szydlo TE; Kang DH; Wahrer DC; Shannon KE; Lubratovich M; Verselis SJ; Isselbacher KJ; Fraumeni JF; Birch JM; Li FP; Garber JE; Haber DA
Science; 1999 Dec; 286(5449):2528-31. PubMed ID: 10617473
[TBL] [Abstract][Full Text] [Related]
13. [Li-Fraumeni syndrome and the p53 gene].
Thoresen SO
Tidsskr Nor Laegeforen; 1992 Mar; 112(7):887-9. PubMed ID: 1557756
[TBL] [Abstract][Full Text] [Related]
14. The first documentation of Li-Fraumeni syndrome in Korea.
Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
[TBL] [Abstract][Full Text] [Related]
15. Li-Fraumeni syndrome in a Malaysian kindred.
Ariffin H; Martel-Planche G; Daud SS; Ibrahim K; Hainaut P
Cancer Genet Cytogenet; 2008 Oct; 186(1):49-53. PubMed ID: 18786442
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
MacGeoch C; Turner G; Bobrow LG; Barnes DM; Bishop DT; Spurr NK
J Med Genet; 1995 Mar; 32(3):186-90. PubMed ID: 7783166
[TBL] [Abstract][Full Text] [Related]
17. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
[TBL] [Abstract][Full Text] [Related]
18. [Li-Fraumeni syndrome].
Alonso-Cerezo MC; Pérez-Pérez P
Med Clin (Barc); 2011 Oct; 137(9):425-6. PubMed ID: 21345471
[No Abstract] [Full Text] [Related]
19. New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer.
Evans DG; Woodward ER
Fam Cancer; 2021 Jan; 20(1):1-7. PubMed ID: 32984917
[No Abstract] [Full Text] [Related]
20. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
